Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
Authors:
Open Access
- 1 April 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (4) , 641-650
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cell Surface Nucleolin Serves as Receptor for DNA Nanoparticles Composed of Pegylated Polylysine and DNAMolecular Therapy, 2008
- Efficacy of nonviral gene transfer in the canine brainJournal of Neurosurgery, 2007
- Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticlesGene Therapy, 2006
- Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoterGene Therapy, 2001
- Neuron-Specific Expression of Therapeutic Proteins: Evaluation of Different Cellular Promoters in Recombinant Adenoviral VectorsMolecular and Cellular Neuroscience, 2001
- Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's DiseaseScience, 2000
- Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan diseaseAnnals of Neurology, 2000
- Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal SystemThe Journal of Neuroscience, 2000
- Noninvasive gene targeting to the brainProceedings of the National Academy of Sciences, 2000
- Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's DiseaseExperimental Neurology, 1999